These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37018966)

  • 1. Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study.
    Bokkers K; Bleiker EMA; Velthuizen ME; Koelemij R; Burgmans JPJ; Klinkenbijl JH; Schouten van der Velden AP; Vermulst N; Huizinga BF; Witkamp AJ; Frakking T; Brohet RM; Aalfs CM; Koole W; Schoenmaeckers EJP; Ausems MGEM
    Breast; 2023 Jun; 69():349-357. PubMed ID: 37018966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.
    Bokkers K; Bleiker EMA; Hoogendam JP; Velthuizen ME; Schreuder HWR; Gerestein CG; Lange JG; Louwers JA; Koudijs MJ; Ausems MGEM; Zweemer RP
    Hered Cancer Clin Pract; 2022 Sep; 20(1):33. PubMed ID: 36076240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
    Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
    BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.
    Bokkers K; Bleiker EMA; Aalfs CM; van Dalen T; Velthuizen ME; Duijveman P; Sijmons RH; Koole W; Schoenmaeckers EJP; Ausems MGEM
    Ann Surg Oncol; 2023 Jun; 30(6):3248-3258. PubMed ID: 36853565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
    Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
    BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
    McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
    Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
    Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
    Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
    Scheinberg T; Young A; Woo H; Goodwin A; Mahon KL; Horvath LG
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):163-177. PubMed ID: 32309911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
    Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
    Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a plain-language guide for discussing breast cancer genetic counseling and testing with patients with limited health literacy.
    van der Giessen JAM; Ausems MGEM; van Riel E; de Jong A; Fransen MP; van Dulmen S
    Support Care Cancer; 2021 Jun; 29(6):2895-2905. PubMed ID: 33001269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.
    Al-Hilli Z; Noss R; Dickard J; Wei W; Chichura A; Wu V; Renicker K; Pederson HJ; Eng C
    Ann Surg Oncol; 2023 Oct; 30(10):5990-5996. PubMed ID: 37567976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
    Bokkers K; Frederix GWJ; Velthuizen ME; van der Aa M; Gerestein CG; van Dorst EBL; Lange JG; Louwers JA; Koole W; Zweemer RP; Ausems MGEM
    Gynecol Oncol; 2022 Oct; 167(1):115-122. PubMed ID: 36031452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.
    Sweet K; Reiter PL; Schnell PM; Senter L; Shane-Carson KP; Aeilts A; Cooper J; Spears C; Brown J; Toland AE; Agnese DM; Katz ML
    Contemp Clin Trials; 2023 Oct; 133():107323. PubMed ID: 37661005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
    Eijzenga W; Aaronson NK; Kluijt I; Sidharta GN; Hahn DE; Ausems MG; Bleiker EM
    BMC Cancer; 2014 Jan; 14():26. PubMed ID: 24428912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis.
    Kritzik R; Usoro E; Peshkin BN; Isaacs C; Valdimarsdottir HB; Willey S; O'Neill S; DeMarco T; Nusbaum R; Jandorf L; Kelleher S; Schwartz MD
    Psychooncology; 2022 May; 31(5):788-797. PubMed ID: 34921700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.